Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Update

Curative Biotechnology, Inc. (OTCMKTS:CUBT) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 42,000 shares, a growth of 452.6% from the June 15th total of 7,600 shares. Based on an average daily volume of 520,700 shares, the short-interest ratio is presently 0.1 days.

Curative Biotechnology Price Performance

Shares of CUBT stock remained flat at $0.02 during trading hours on Friday. Curative Biotechnology has a 1 year low of $0.00 and a 1 year high of $0.04. The firm has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.02.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.